American International Group’s Cabaletta Bio CABA Stock Holding History

American International Group’s Portfolio CABA Stock Details CABA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-16,971	Closed	-$290K	–	436
2024 Q1	$290K	Sell	16,971 -147	-0.9%	-$3.15K	﹤0.01%	1935
2023 Q4	$389K	Sell	17,118 -68	-0.4%	-$1.14K	﹤0.01%	1810
2023 Q3	$262K	Buy	17,186 +4,875	+40%	+$66.6K	﹤0.01%	1975
2023 Q2	$159K	Buy	+12,311	New	+$134K	﹤0.01%	2302
2021 Q2	–	Sell	-7,524	Closed	-$84	–	3133
2021 Q1	$84	Buy	7,524 +20	+0.3%	+$244	﹤0.01%	2789
2020 Q4	$94	Sell	7,504 -216	-3%	-$2.8K	﹤0.01%	2690
2020 Q3	$84K	Sell	7,720 -176	-2%	-$2.02K	﹤0.01%	2615
2020 Q2	$88K	Buy	7,896 +3,960	+101%	+$30.3K	﹤0.01%	2603
2020 Q1	$29K	Sell	3,936 -145	-4%	-$1.99K	﹤0.01%	2855
2019 Q4	$57K	Buy	+4,081	New	+$48.4K	﹤0.01%	2846

Other funds holding CABA

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

American International Group's CABA Position: Q2 2024 in Review

American International Group sold out of Cabaletta Bio (CABA) in Q2 2024, closing a stake of 16,971 shares — an estimated $290K sold.

American International Group first reported a position in CABA in Q4 2019 and held it in 10 quarters. The position peaked at $389K in Q4 2023. 142 funds tracked by Wall St. Rank hold CABA as of Q2 2024.

American International Group reported no remaining Cabaletta Bio position as of Q2 2024 after selling out during the quarter.
American International Group sold 16,971 Cabaletta Bio shares in Q2 2024, an estimated $290K.
American International Group first reported a position in Cabaletta Bio in Q4 2019 and held it in 10 quarters.
American International Group's Cabaletta Bio position peaked at $389K in Q4 2023.
142 funds tracked by Wall St. Rank held Cabaletta Bio as of Q2 2024.

Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.